NextGen Metabolomics Inc.
Life Science researchers rely on metabolomics or the measurement of metabolites (eg glucose and cholesterol), to inform them about disease, drugs, and experi...
- Stage Prototype Ready
- Industry Biotechnology
- Location Ann Arbor, MI, USA
- Currency USD
- Founded June 2010
- Website nextgenmetabolomics.com
Company Summary
Life Science researchers rely on metabolomics or the measurement of metabolites (eg glucose and cholesterol), to inform them about disease, drugs, and experimental effects. NextGen Metabolomics has patented metabolomics tools that automate the measurement of all 2,000 metabolites from samples such as biopsies, urine or blood. Fast, clear, concise biological information is generated to produce better drugs, diagnostics, crops, biofuels etc.
Team
-
Chris BeecherChief Scientific Officer
Renowned Metabolomics science and technology pioneer;
Co-founder of current metabolomics leader, Metabolon, Inc.;
Inventor on 12 patents; 75+ publications -
Felice A de JongChief Executive Officer
25+ yrs in the Life Science industry; PhD biochemistry; technology business degree;
Founding President of Sigma-Aldrich Australia;
President, Sigma-Aldrich RBI;
6 yrs Marketing/Sales/Business Dev. for early stage Metabolomics Company
Advisors
-
Enterprise Law PartnersLawyerUnconfirmedSHAH & ASSOCIATES, CPA, PCAccountantUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.